Copyright Reports & Markets. All rights reserved.

Global Blood Plasma Fractionation Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Blood Plasma Fractionation Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Immune Globulin
    • 1.3.3 Coagulation Factor
    • 1.3.4 Albumin
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Blood Plasma Fractionation Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Blood Plasma Fractionation Market Size & Forecast
    • 1.5.1 Global Blood Plasma Fractionation Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Blood Plasma Fractionation Sales Quantity (2019-2030)
    • 1.5.3 Global Blood Plasma Fractionation Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Takeda
    • 2.1.1 Takeda Details
    • 2.1.2 Takeda Major Business
    • 2.1.3 Takeda Blood Plasma Fractionation Product and Services
    • 2.1.4 Takeda Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Takeda Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Blood Plasma Fractionation Product and Services
    • 2.2.4 CSL Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 Grifols
    • 2.3.1 Grifols Details
    • 2.3.2 Grifols Major Business
    • 2.3.3 Grifols Blood Plasma Fractionation Product and Services
    • 2.3.4 Grifols Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Grifols Recent Developments/Updates
  • 2.4 Octapharma
    • 2.4.1 Octapharma Details
    • 2.4.2 Octapharma Major Business
    • 2.4.3 Octapharma Blood Plasma Fractionation Product and Services
    • 2.4.4 Octapharma Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Octapharma Recent Developments/Updates
  • 2.5 Kedrion
    • 2.5.1 Kedrion Details
    • 2.5.2 Kedrion Major Business
    • 2.5.3 Kedrion Blood Plasma Fractionation Product and Services
    • 2.5.4 Kedrion Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Kedrion Recent Developments/Updates
  • 2.6 LFB Group
    • 2.6.1 LFB Group Details
    • 2.6.2 LFB Group Major Business
    • 2.6.3 LFB Group Blood Plasma Fractionation Product and Services
    • 2.6.4 LFB Group Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 LFB Group Recent Developments/Updates
  • 2.7 Biotest
    • 2.7.1 Biotest Details
    • 2.7.2 Biotest Major Business
    • 2.7.3 Biotest Blood Plasma Fractionation Product and Services
    • 2.7.4 Biotest Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Biotest Recent Developments/Updates
  • 2.8 BPL
    • 2.8.1 BPL Details
    • 2.8.2 BPL Major Business
    • 2.8.3 BPL Blood Plasma Fractionation Product and Services
    • 2.8.4 BPL Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 BPL Recent Developments/Updates
  • 2.9 RAAS
    • 2.9.1 RAAS Details
    • 2.9.2 RAAS Major Business
    • 2.9.3 RAAS Blood Plasma Fractionation Product and Services
    • 2.9.4 RAAS Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 RAAS Recent Developments/Updates
  • 2.10 CBPO
    • 2.10.1 CBPO Details
    • 2.10.2 CBPO Major Business
    • 2.10.3 CBPO Blood Plasma Fractionation Product and Services
    • 2.10.4 CBPO Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 CBPO Recent Developments/Updates
  • 2.11 Hualan Bio
    • 2.11.1 Hualan Bio Details
    • 2.11.2 Hualan Bio Major Business
    • 2.11.3 Hualan Bio Blood Plasma Fractionation Product and Services
    • 2.11.4 Hualan Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Hualan Bio Recent Developments/Updates
  • 2.12 Tiantan Bio
    • 2.12.1 Tiantan Bio Details
    • 2.12.2 Tiantan Bio Major Business
    • 2.12.3 Tiantan Bio Blood Plasma Fractionation Product and Services
    • 2.12.4 Tiantan Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Tiantan Bio Recent Developments/Updates
  • 2.13 Shuanglin Bio
    • 2.13.1 Shuanglin Bio Details
    • 2.13.2 Shuanglin Bio Major Business
    • 2.13.3 Shuanglin Bio Blood Plasma Fractionation Product and Services
    • 2.13.4 Shuanglin Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Shuanglin Bio Recent Developments/Updates
  • 2.14 Boya Bio
    • 2.14.1 Boya Bio Details
    • 2.14.2 Boya Bio Major Business
    • 2.14.3 Boya Bio Blood Plasma Fractionation Product and Services
    • 2.14.4 Boya Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Boya Bio Recent Developments/Updates
  • 2.15 Yuanda Shuyang
    • 2.15.1 Yuanda Shuyang Details
    • 2.15.2 Yuanda Shuyang Major Business
    • 2.15.3 Yuanda Shuyang Blood Plasma Fractionation Product and Services
    • 2.15.4 Yuanda Shuyang Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Yuanda Shuyang Recent Developments/Updates
  • 2.16 Weiguang Bio
    • 2.16.1 Weiguang Bio Details
    • 2.16.2 Weiguang Bio Major Business
    • 2.16.3 Weiguang Bio Blood Plasma Fractionation Product and Services
    • 2.16.4 Weiguang Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Weiguang Bio Recent Developments/Updates
  • 2.17 Nanyue Bio
    • 2.17.1 Nanyue Bio Details
    • 2.17.2 Nanyue Bio Major Business
    • 2.17.3 Nanyue Bio Blood Plasma Fractionation Product and Services
    • 2.17.4 Nanyue Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Nanyue Bio Recent Developments/Updates
  • 2.18 KM Biologics
    • 2.18.1 KM Biologics Details
    • 2.18.2 KM Biologics Major Business
    • 2.18.3 KM Biologics Blood Plasma Fractionation Product and Services
    • 2.18.4 KM Biologics Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Blood Plasma Fractionation by Manufacturer

  • 3.1 Global Blood Plasma Fractionation Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Blood Plasma Fractionation Revenue by Manufacturer (2019-2024)
  • 3.3 Global Blood Plasma Fractionation Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Blood Plasma Fractionation by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Blood Plasma Fractionation Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Blood Plasma Fractionation Manufacturer Market Share in 2023
  • 3.5 Blood Plasma Fractionation Market: Overall Company Footprint Analysis
    • 3.5.1 Blood Plasma Fractionation Market: Region Footprint
    • 3.5.2 Blood Plasma Fractionation Market: Company Product Type Footprint
    • 3.5.3 Blood Plasma Fractionation Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Blood Plasma Fractionation Market Size by Region
    • 4.1.1 Global Blood Plasma Fractionation Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Blood Plasma Fractionation Consumption Value by Region (2019-2030)
    • 4.1.3 Global Blood Plasma Fractionation Average Price by Region (2019-2030)
  • 4.2 North America Blood Plasma Fractionation Consumption Value (2019-2030)
  • 4.3 Europe Blood Plasma Fractionation Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Blood Plasma Fractionation Consumption Value (2019-2030)
  • 4.5 South America Blood Plasma Fractionation Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Blood Plasma Fractionation Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Blood Plasma Fractionation Sales Quantity by Type (2019-2030)
  • 5.2 Global Blood Plasma Fractionation Consumption Value by Type (2019-2030)
  • 5.3 Global Blood Plasma Fractionation Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Blood Plasma Fractionation Sales Quantity by Application (2019-2030)
  • 6.2 Global Blood Plasma Fractionation Consumption Value by Application (2019-2030)
  • 6.3 Global Blood Plasma Fractionation Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Blood Plasma Fractionation Sales Quantity by Type (2019-2030)
  • 7.2 North America Blood Plasma Fractionation Sales Quantity by Application (2019-2030)
  • 7.3 North America Blood Plasma Fractionation Market Size by Country
    • 7.3.1 North America Blood Plasma Fractionation Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Blood Plasma Fractionation Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Blood Plasma Fractionation Sales Quantity by Type (2019-2030)
  • 8.2 Europe Blood Plasma Fractionation Sales Quantity by Application (2019-2030)
  • 8.3 Europe Blood Plasma Fractionation Market Size by Country
    • 8.3.1 Europe Blood Plasma Fractionation Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Blood Plasma Fractionation Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Blood Plasma Fractionation Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Blood Plasma Fractionation Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Blood Plasma Fractionation Market Size by Region
    • 9.3.1 Asia-Pacific Blood Plasma Fractionation Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Blood Plasma Fractionation Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Blood Plasma Fractionation Sales Quantity by Type (2019-2030)
  • 10.2 South America Blood Plasma Fractionation Sales Quantity by Application (2019-2030)
  • 10.3 South America Blood Plasma Fractionation Market Size by Country
    • 10.3.1 South America Blood Plasma Fractionation Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Blood Plasma Fractionation Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Blood Plasma Fractionation Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Blood Plasma Fractionation Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Blood Plasma Fractionation Market Size by Country
    • 11.3.1 Middle East & Africa Blood Plasma Fractionation Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Blood Plasma Fractionation Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Blood Plasma Fractionation Market Drivers
  • 12.2 Blood Plasma Fractionation Market Restraints
  • 12.3 Blood Plasma Fractionation Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Blood Plasma Fractionation and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Blood Plasma Fractionation
  • 13.3 Blood Plasma Fractionation Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Blood Plasma Fractionation Typical Distributors
  • 14.3 Blood Plasma Fractionation Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Human blood plasma is nature"s raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
    According to our (Global Info Research) latest study, the global Blood Plasma Fractionation market size was valued at US$ 31210 million in 2023 and is forecast to a readjusted size of USD 51340 million by 2030 with a CAGR of 7.5% during review period.
    Global key blood plasma fractionation players include CSL, Grifols and Takeda etc. The top 3 companies hold a share about 55%. North America is the largest market with a share about 40%, followed by Asia-Pacific and Europe.
    In terms of product, Immune Globulin is the largest segment with a share about 50%. And in terms of applications, the largest application is hospital with a share about 70%.
    This report is a detailed and comprehensive analysis for global Blood Plasma Fractionation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Blood Plasma Fractionation market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Blood Plasma Fractionation market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Blood Plasma Fractionation market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Blood Plasma Fractionation market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Blood Plasma Fractionation
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Blood Plasma Fractionation market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Blood Plasma Fractionation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Immune Globulin
    Coagulation Factor
    Albumin
    Other
    Market segment by Application
    Hospital
    Retail Pharmacy
    Other
    Major players covered
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio
    Tiantan Bio
    Shuanglin Bio
    Boya Bio
    Yuanda Shuyang
    Weiguang Bio
    Nanyue Bio
    KM Biologics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Blood Plasma Fractionation product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Blood Plasma Fractionation, with price, sales quantity, revenue, and global market share of Blood Plasma Fractionation from 2019 to 2024.
    Chapter 3, the Blood Plasma Fractionation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Blood Plasma Fractionation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Blood Plasma Fractionation market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Plasma Fractionation.
    Chapter 14 and 15, to describe Blood Plasma Fractionation sales channel, distributors, customers, research findings and conclusion.

    Buy now